-
United Therapeutics Converts to a Public Benefit Corporation
Downtown Silver Spring-based United Therapeutics Corporation yesterday announced that following shareholder approval, it has officially converted to a public benefit corporation (PBC), the first PBC conversion of a public biotech or pharmaceutical company.
-
County Pauses Use of Johnson & Johnson Vaccine
Following recommendations from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), Montgomery County will pause the use of the single-dose Johnson & Johnson COVID-19 vaccine, according to a press release issued today.
-
United Therapeutics Secures Second FDA Approval for Pulmonary Hypertension Drug
Downtown Silver Spring-based United Therapeutics has secured a second Food & Drug Administration approval for its Tyvaso drug, according to a report from Washington Business Journal.
-
Report: United Therapeutics Gains Orphan Status for Lung Disease Drug
Downtown Silver Spring-based United Therapeutics has received an FDA designation that helps to expand the company beyond its core business, according to a report from the Washington Business Journal.
-
DOT to Hold Public Workshop on Ride On Bus Route Changes
The county’s Department of Transportation—Transit Services Division will hold a public workshop tonight (March 3) to present the latest proposed revisions to 10 Ride On bus routes. The workshop will be held at Montgomery Blair High School, 51 University Blvd. East, at 6:30 p.m.
-
Spring Street to House United Therapeutics New Manufacturing Facility
A Spring Street property that once housed United Therapeutics’ IT group will become the company’s newest manufacturing facility later this year.